S-23 S23 CAS: 1010396-29-8

CAS NO: 1010396-29-8
S23 S-23’s chemical name is (2S)-N-(4-cyano-3-trifluoromethylphenyl)-3-(3-fluoro-4-chloro-phenyl)-2-hydroxy-2-methyl-propanamide. Its molecular formula is C18H13ClF4N2O3 and its formula weight is 416.75 g/mol. The CAS number for S23 S-23 is 1010396-29-8.
Description Review
Description
S23 S-23 are: S23 S-23 benefits; S23 S-23 dosage; S23 S-23 cycle; S23 S-23 results; S23 S-23 reviews.

Other synonyms used to refer to S23 S-23 include: MK-677, Ligandrol, RAD140, Ostarine, Andarine.

Health Benefits

There is limited research available on the health benefits of S23 S-23. However, it is believed that S23 S-23 may be beneficial for the following health conditions:

  • Muscle wasting: S23 S-23 has been shown to help prevent muscle wasting, making it useful for those who suffer from muscle wasting disorders such as HIV/AIDS and cancer.
  • Osteoporosis: S23 S-23 may help improve bone density, making it useful for those who suffer from osteoporosis.
  • Androgen deficiency: S23 S-23 may help increase testosterone levels, making it useful for those who suffer from androgen deficiency.

Potential Effects

S23 S-23 has several potential effects, including:

  • Increased muscle mass: S23 S-23 is believed to be one of the most potent SARMs available today, and it has been shown to help increase muscle mass.
  • Fat loss: S23 S-23 may help promote fat loss, making it useful for those who want to lose weight.
  • Improved endurance: S23 S-23 may help improve endurance, making it useful for athletes who want to improve their performance.
  • Increased bone density: S23 S-23 may help improve bone density, making it useful for those who suffer from osteoporosis.

Mechanisms

S23 S-23 works by binding to androgen receptors in the body. This leads to an increase in muscle protein synthesis, which in turn helps to build muscle mass. S23 S-23 also helps to reduce the breakdown of muscle tissue, which can help prevent muscle wasting. Additionally, S23 S-23 may increase bone density by promoting osteoblast activity.

Safety

There is limited research available on the safety of S23 S-23. However, like other SARMs, S23 S-23 is believed to be safer than traditional anabolic steroids. It is important to note that long-term use of S23 S-23 may have negative health effects, and more research is needed to determine the long-term safety of this drug.

Side Effects

S23 S-23 may cause a number of side effects, including:

  • Mood swings
  • Acne
  • Hair loss
  • Decreased libido
  • Testicular atrophy
  • Night blindness

Dosage Information

There is no established dosage for S23 S-23. However, most experts recommend starting with a low dose and gradually increasing it over time. The recommended dosage ranges from 10mg to 30mg per day. It is important to note that S23 S-23 is a powerful substance, and users should be careful when dosing.

Conclusion

S23 S-23 is a powerful SARM that has gained popularity among bodybuilders and athletes in recent years. It has several potential benefits, including increased muscle mass, fat loss, improved endurance, and increased bone density. However, there is limited research available on the safety and long-term effects of S23 S-23. As with any substance, users should exercise caution when dosing and be aware of the potential side effects.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us